AF
CRBU icon

Allworth Financial’s Caribou Biosciences CRBU Stock Holding History

Allworth Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,430
Closed -$17.9K – 5198
2026
Q1 		$17.9K Hold
9,430
– – ﹤0.01% 3072
2025
Q4 		$15K Buy
+9,430
New +$19.8K ﹤0.01% 2991
2025
Q3 		– Sell
-156
Closed -$197 – 4936
2025
Q2 		$197 Buy
+156
New +$153 ﹤0.01% 4316
2023
Q1 		– Sell
-530
Closed -$3.33K – 3212
2022
Q4 		$3.33K Hold
530
– – ﹤0.01% 2052
2022
Q3 		$6K Hold
530
– – ﹤0.01% 1814
2022
Q2 		$3K Hold
530
– – ﹤0.01% 1874
2022
Q1 		$5K Buy
+530
New +$5.58K ﹤0.01% 1621

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allworth Financial's CRBU Position: Q2 2026 in Review

Allworth Financial sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 9,430 shares — an estimated $17.9K sold.

Allworth Financial first reported a position in CRBU in Q1 2022 and held it in 7 quarters. The position peaked at $17.9K in Q1 2026. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Allworth Financial reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Allworth Financial sold 9,430 Caribou Biosciences shares in Q2 2026, an estimated $17.9K.
  • Allworth Financial first reported a position in Caribou Biosciences in Q1 2022 and held it in 7 quarters.
  • Allworth Financial's Caribou Biosciences position peaked at $17.9K in Q1 2026.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.